‘Vaccine Sommeliers’ Go to the End of the Line in One Brazilian Town
(Bloomberg) -- A Brazilian town is taking action against people who are pick and choosing which Covid-19 vaccine they want to take, a move that's delaying a mass immunization campaign in one of the hardest-hit countries in the world.
Sao Bernardo do Campo, a city of about 850,000 people in the outskirts of Sao Paulo, said the so-called “vaccine sommeliers” will be sent to the end of the line if they decline the shot that is available.
The announcement, made by Mayor Orlando Morando on social media on Wednesday night, comes after some 300 people arrived at vaccine posts this week -- appointments are mandatory in Sao Bernardo -- and refused the shots that were at hand.
Many Brazilians Insist on Pfizer Even With 500,000 Covid Deaths
So from today, those who turn down the vaccine being offered will have to sign a term of refusal, which will be stored in the healthcare system's records. They'll only be allowed back once everyone over the age of 18 gets one dose, which is expected to happen in September.
“No one has ever asked about vaccine brands before. Now, in the midst of humanity's greatest pandemic, people want to pick?” the mayor said on the social media feed. “People shouldn't be choosing between vaccines.”
Brazil has struggled to accelerate its vaccination campaign amid a persistent lack of shots. The country has given a first dose to about a third of the population, and fully vaccinated just 12%, according to data compiled by Bloomberg.
The delivery of doses is expected to pick up in the second half, improving the outlook. But while the virus has receded in most of the world, Brazil is still recording some 2,000 daily Covid deaths, and has over 518,000 fatalities from the disease.
©2021 Bloomberg L.P.
-
India's Troika Of Good Luck | Joining The Dots
A weaker Trump, a cooling AI trade and resilient earnings have put Indian markets back in favour. Rising inflation could spoil the party.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.